𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Opportunities for novel therapeutic agents acting at chemokine receptors

✍ Scribed by John Saunders; Christine M. Tarby

Book ID
114385719
Publisher
Elsevier Science
Year
1999
Tongue
English
Weight
370 KB
Volume
4
Category
Article
ISSN
1359-6446

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Allosteric ligands for G protein-coupled
Allosteric ligands for G protein-coupled receptors: A novel strategy with attractive therapeutic opportunities
✍ Marco De Amici; Clelia Dallanoce; Ulrike Holzgrabe; Christian TrΓ€nkle; Klaus Moh πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 865 KB

Allosteric receptor ligands bind to a recognition site that is distinct from the binding site of the endogenous messenger molecule. As a consequence, allosteric agents may attach to receptors that are already transmitter-bound. Ternary complex formation opens an avenue to qualitatively new drug acti

ChemInform Abstract: Corticotropin Relea
ChemInform Abstract: Corticotropin Releasing Factor (CRF) Receptor Modulators: Progress and Opportunities for New Therapeutic Agents
✍ Paul J. Gilligan; David W. Robertson; Robert Zaczek πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons βš– 26 KB

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a β€œFull Text” option. The original article is trackable v

Approach to discovering novel therapeuti
Approach to discovering novel therapeutic agents for osteoporosis based on integrin receptor blockade
✍ Michael Chorev; Rivka Dresner-Pollak; Yoav Eshel; Michael Rosenblatt πŸ“‚ Article πŸ“… 1995 πŸ› Wiley (John Wiley & Sons) 🌐 English βš– 763 KB

On a global scale, osteoporosis is a major and growing public health problem. In the United States, osteoporosis is present in 24 million people (mostly women) and contributes to more than 1.3 million fractures/year. Serious morbidity and mortality result from these fractures. Current therapies for